The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Fresenius Kabi’s Adaptive Nomogram, an alternate algorithm that will be available in the Aurora Xi Plasmapheresis System designed to optimize plasma collection efficiency. The newly cleared Adaptive Nomogram considers each donor’s individual characteristics in calculating the volume of plasma to collect, enabling an average 11.5% increase in plasma collection per donation while maintaining safe and effective operatio...